Medifast FY 2021: revenue $1.5B; diluted EPS $13.89

Key figures from this report

These are the numbers Medifast reported for the year ended Dec 31, 2021, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

1. Revenue$1.5BNo year-earlier figure tagged10-K income statement, on EDGAR
2. Net income$164.0M+59% from $102.9M in FY 202010-K income statement, on EDGAR
3. Diluted EPS$13.89+60% from $8.68 in FY 202010-K income statement, on EDGAR
4. Cash and cash equivalents$104.2M−36% from $163.7M in FY 2020Cash and equivalents only; the company page adds short-term investments.10-K balance sheet, on EDGAR
5. Cash from operations$94.5M−35% from $145.2M in FY 202010-K cash flow statement, on EDGAR

Every year in the financial tables